Women’s health devices market seen reaching $77.08 billion by 2030

The women’s health devices market is projected to grow from $44.2 billion in 2025 to $77.08 billion by 2030, driven by rising chronic disease rates, digital health adoption and demand for more personalized care. North America leads now, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Women’s health devices are gaining traction as health systems and consumers look for earlier detection, continuous monitoring and more personalized care. - The category spans maternal health, menstrual health, fertility, menopause, contraception and related conditions such as osteoporosis and cardiovascular disease. - Rising chronic disease prevalence is expanding demand for tools that can support ongoing management and improve outcomes.

What happened: - The Business Research Company said the women’s health devices market will rise from $44.2 billion in 2025 to $49.48 billion in 2026. - The market is forecast to reach $77.08 billion by 2030, implying an 11.7% CAGR over the forecast period. - The company released the outlook on Sept. 3, 2026, from London. - The report includes a free sample and a full market report: Download a free sample and View the full report.

The details: - The market grew on higher awareness of women’s health issues, preventive healthcare programs, better access to diagnostics, more focus on maternal health and wider use of digital health technologies. - The company expects growth to be fueled by more femtech investment, stronger demand for tailored healthcare solutions, broader telehealth access, more wearable health devices and greater use of data-driven insights. - Emerging trends include connected health devices, more at-home diagnostic kits, tighter integration of digital health platforms, growth in fertility and menstrual tracking tools and more individualized care. - Women’s health devices are designed to help women manage health data, often through at-home testing and other user-friendly features. - The devices support care across multiple categories, including maternal and menstrual health, pelvic and sexual well-being, fertility, menopause and contraception. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report additions include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.

Between the lines: - The forecast points to a market moving from broad awareness to more specialized, data-heavy care. - The emphasis on at-home diagnostics and connected devices suggests women’s health is shifting further outside traditional clinic settings. - The chronic disease driver also broadens the market beyond reproductive care into long-term monitoring and management. - UK National Health Service data cited in the report showed 3,615,330 people registered with general practitioners were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, up 18% from 3,065,825 in 2022.

What's next: - North America is expected to remain the largest market in 2025. - Asia-Pacific is projected to be the fastest-growing region across the forecast period. - The market will likely continue to be shaped by telehealth adoption, wearable devices and digitally enabled self-monitoring.

The bottom line: - Women’s health devices are moving from a niche category to a broader digital health market with strong growth ahead and expanding clinical use cases.